Clomipramine, Fluoxetine, and Glucose Control

References

• Rudorfer MV, Potter WZ: Pharmacokinetics of Antidepressants. In Meltzer HY (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven, 1987, p 1354
   Google Scholar
• Fuller RW, Wong DT: Inhibition of serotonin reuptake. Fed Proc 36:2154–2158, 1977
   PubMedGoogle Scholar
• Baldessarini RJ: Drugs and the Treatment of Psychiatric Disorders. In Gilman AG, Goodman LS, Rall TW, Murad F (eds): Goodman and Gilman–s The Pharmacologic Basis of Therapeutics, 7th ed. New York, Mamillan, 1985, p 417
   Google Scholar
• Jacoby JH, Bryce GF: The acute effects of SHTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat. Hormon Metab Res 11:90–94, 1979
   Google Scholar
• Wilson GA, Furman BL: Effects of inhibitors of 5- hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycemia in mice. Eur J Pharmacol78:263–270, 1982
   PubMed Web of Science ®Google Scholar
• Fuller RW, Snoddy HB: Elevation of plasma corticosterone by swim stress and insulin-induced hypoglycemia in control and fluoxetine-pretreated rats. Endocr Res Commun 4:11–23, 1977
   Web of Science ®Google Scholar
• Fuller RW: Serotonergic stimulation of pituitaryadreno- cortical function in rats. Neuroendocrinology 32118–127, 1981
   Google Scholar
• Gibbs DM, Vale W: Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood. Brain Res 280:176–179, 1983
   PubMedGoogle Scholar
• Plonk JW, Bivens CH, Feldman JM: Inhibition of hypoglycemia- induced cortisol secretion by the serotonin antagonist cyproheptadine. J Clin Endocrinol Metab 38:836–840, 1974
   PubMedGoogle Scholar
• Ahren B, Taborsky Jr GJ, Porte D Jr: Neuropeptide versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia 29:827–836, 1986
   PubMed Web of Science ®Google Scholar
• Shian LR, Lin MT: Stimulation of a bulbospinal 5-HT pathway in the rat brain produces hyperglycaemia. Pflugers Arch 4163604–608, 1990
   Google Scholar
• Gregorio F, Filipponi P, CristaUini S, Carloni C, Moretti I, Ferrandina C, Pippi R, Pietropaola M: Effects of beta nonselective and beta, selective adrenergic blocking agents on glucagon secretion from isolated perfused rat pancreas. J Endocrinol Invest 9:209–215, 1986
   Google Scholar
• Zielmann S, Schutte G, Lenzen S, Panten U: Effects of isoprenaline and glucagon on insulin secretion from pancreatic islets. Arch Pharmacol329:299–304, 1985
   Google Scholar
• Hillaire-Buys D, Gross R, Blayac JP, Ribes G, Loubatieres- Mariani MM: Effects of alpha-adrenoceptor agonists and antagonists on insulin secreting cells and pancreatic blood vessels: comparative study. Eur J Pharmacol 117:253–257, 1985
   Google Scholar
• Anderson PO, Holst J, Jarhult J: Effects of adrenergic blockade on the release of insulin, glucagon and somatostatin from the pancreas in response to splanchnic nerve stimulation in cats. Acta Physiol Scand 116:403–409, 1982
   Google Scholar
• Oda S, Ohtomo Y, Ohneda A, Sasaki Y, Tsuda T: Adrenergic modulation of pancreatic glucagon and insulin secretion in goats. Comp Biochem Physiol4:723–728, 1986
   Google Scholar
• Quickel KE Jr, Feldman JM, Lebovitz HE: Enhancement of insulin secretion in adult onset diabetics by methysergide maleate: Evidence for an endogenous biogenic monoamine mechanism as a factor in the impaired insulin secretion in diabetes mellitus. J Clin Endocrinol33:877–881, 1971
   Google Scholar
• Marco J, Hedo JA, Martinell J, Calle C, Villanueva ML: Potentiation of glucagon secretion by serotonin antagonists in man. J Clin Endocrinol Metab 642:215–221, 1976
   Google Scholar
• Martin JB, Reichlin S: Clinical Neuroendocrinology. In Contemporary Neurology Series, 2nd ed. Philadelphia, Davis, 1987 vol 28, pp 46–51, 159–177
   Google Scholar
• Lundquist I: Cholinergic muscarinic effects on insulin release in mice. Pharmacology 25:338–347, 1982
   Google Scholar
• de Leiva A, Tanenberg RJ, Anderson G, Greenberg B, Senske B, Goetz FB: Serotoninergic activation and inhibition: Effects on carbohydrate tolerance and plasma insulin and glucagon. Metabolism 27 (5):511–520,1978
   Google Scholar
• Jacoby JH, Bryce GF: The acute pharmacologic effects of serotonin on the release of insulin and glucagon in the intact rat. Arch Int Pharmacodyn: 235:254–270,1978
   PubMedGoogle Scholar
• Rasmussen H, Zawalich KC, Ganesan S, Cde R, Zawalich WS, Physiology and pathophysiology of insulin secretion. Diabetes Care 6:655–666, 1990
   Google Scholar
• Paykel ES, Mueller PS, De La Vergne: Amitriptyline, weight gain and carbohydrate craving: A side effect. Br J Psychiatry 123:501–507, 1973
   PubMed Web of Science ®Google Scholar